Genertec Universal Medical Group Company Limited (UMTAF) Research
Genertec Universal Medical Group Company Limited (UMTAF), established in 1984 and headquartered in Beijing, China, delivers a comprehensive suite of financial and advisory services throughout the People's Republic of China, primarily targeting the medical industry. The company operates through two core divisions: Finance and Advisory, and Hospital Group. Its Finance and Advisory segment provides diverse financial solutions, including direct finance leasing, sale and leaseback transactions, factoring, operating leases, and various consulting services. Meanwhile, the Hospital Group segment is engaged in delivering medical care, managing hospitals and healthcare facilities, and facilitating the import, export, and trade of medical-related goods. Beyond these segments, the company's offerings also encompass medical technology development, hospital digitalization, construction, and management, property management, and medical consulting expertise. It caters to a wide array of clients, including patients, healthcare institutions, medical equipment vendors, and other public entities. The organization, previously known as Universal Medical Financial & Technical Advisory Services Company Limited, adopted its current name in July 2018.
Market snapshot
- Symbol
- UMTAF
- Price
- $0.60
- Day change
- +8.18%
- Market cap
- $8.6B
- P/E ratio
- 3.98x
- 52-week range
- 0.595-0.595
- Sector
- Financial Services
- Industry
- Financial - Credit Services
Peer companies
Open Genertec Universal Medical Group Company Limited (UMTAF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.